Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ Global MarketTotal Valuation
Shuttle Pharmaceuticals Holdings, Inc. carries a market capitalization of 2.09M, placing it among publicly traded companies globally. Its enterprise value stands at -693,325.20, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.09M |
| Enterprise Value | -693,325.20 |
Share Statistics
Shuttle Pharmaceuticals Holdings, Inc. currently has 555,129.00 shares outstanding.
| Shares Outstanding | 555,129.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.00 |
| P/TBV Ratio | -0.03 |
| P/FCF Ratio | -0.02 |
| P/OCF Ratio | -0.02 |
Financial Position
Shuttle Pharmaceuticals Holdings, Inc. maintains a current ratio of 0.30, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.40, indicating elevated leverage, while an interest coverage ratio of -144.47 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.30 |
| Quick Ratio | 0.13 |
| Debt / Equity | 6.40 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | -144.47 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -126.42 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Shuttle Pharmaceuticals Holdings, Inc.'s stock has declined approximately -91.13861% over the past 52 weeks. The 50-day moving average sits at 5.92, while the 200-day moving average is 16.64.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.13861% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 16.64 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -10.26M, while operating income came in at -11.18M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -11.18M |
| Pretax Income | -10.82M |
| Net Income | -10.82M |
| EBITDA | -10.26M |
| EBIT | -11.18M |
| Earnings Per Share (EPS) | -38.69 |
Balance Sheet
Shuttle Pharmaceuticals Holdings, Inc. holds 1.09M in cash and equivalents against 214,013.00 in total debt, resulting in a net debt position of -1.09M. Total book value stands at -48.45M, with working capital of -5.84M providing operational flexibility.
| Cash & Cash Equivalents | 1.09M |
| Total Debt | 214,013.00 |
| Net Debt | -1.09M |
| Equity (Book Value) | -48.45M |
| Book Value Per Share | -173.22 |
| Working Capital | -5.84M |
Cash Flow
Shuttle Pharmaceuticals Holdings, Inc. produced -9.37M in operating cash flow over the past twelve months.
| Operating Cash Flow | -9.37M |
| Capital Expenditures | N/A |
| Free Cash Flow | -9.37M |
| FCF Per Share | -33.51 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4,951.65 |
| FCF Yield | -5,132.33 |
Stock Splits
Shuttle Pharmaceuticals Holdings, Inc.'s most recent stock split took place on June 11, 2026 with a 10:1 split ratio.
| Last Split Date | 6/11/2026 |
| Split Ratio | 10:1 |
Scores
Shuttle Pharmaceuticals Holdings, Inc. posts an Altman Z-Score of -43.56, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -43.56 |